SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-072056
Filing Date
2020-06-10
Accepted
2020-06-10 17:01:01
Documents
3
Period of Report
2020-06-09
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2021357-5_8k.htm 8-K 21448
2 EXHIBIT 16.1 tm2021357d5_ex16-1.htm EX-16.1 4432
3 GRAPHIC tm2021357d5_ex16-1img001.jpg GRAPHIC 2478
  Complete submission text file 0001104659-20-072056.txt   30775
Mailing Address 520 U.S. HIGHWAY 22, SUITE 204 BRIDGEWATER NJ 08807
Business Address 520 U.S. HIGHWAY 22, SUITE 204 BRIDGEWATER NJ 08807 800-775-7936
Menlo Therapeutics Inc. (Filer) CIK: 0001566044 (see all company filings)

IRS No.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38356 | Film No.: 20955359
SIC: 2834 Pharmaceutical Preparations